Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

GS Nowakowski; W Willenbacher; Richard Greil; TS Larsen; K Patel; U Jager; RF Manges; L Trumper; H Everaus; N Kalakonda; P Brown; JM Jorgensen; D Cunningham; J DellxxxAringa; B Fox; ND Rubio; N Kilavuz; ML Casadebaig; O Manzke; J Munoz

doi:10.1007/s12185-021-03241-4

Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

GS Nowakowski, W Willenbacher, Richard Greil (Co-author), TS Larsen, K Patel, U Jager, RF Manges, L Trumper, H Everaus, N Kalakonda, P Brown, JM Jorgensen, D Cunningham, J DellxxxAringa, B Fox, ND Rubio, N Kilavuz, ML Casadebaig, O Manzke, J Munoz

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

18 Citations (Web of Science)

Original language	English
Journal	INTERNATIONAL JOURNAL OF HEMATOLOGY
DOIs	https://doi.org/10.1007/s12185-021-03241-4
Publication status	Published - 2021

Keywords

B-CELL LYMPHOMA
RITUXIMAB PLUS CYCLOPHOSPHAMIDE
DEATH-LIGAND 1
GENE-EXPRESSION
DOXORUBICIN
SURVIVAL
VINCRISTINE
SUBTYPES
INDUCE

Access to Document

10.1007/s12185-021-03241-4

Cite this

Nowakowski, GS., Willenbacher, W., Greil, R., Larsen, TS., Patel, K., Jager, U., Manges, RF., Trumper, L., Everaus, H., Kalakonda, N., Brown, P., Jorgensen, JM., Cunningham, D., DellxxxAringa, J., Fox, B., Rubio, ND., Kilavuz, N., Casadebaig, ML., Manzke, O., & Munoz, J. (2021). Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial. INTERNATIONAL JOURNAL OF HEMATOLOGY. https://doi.org/10.1007/s12185-021-03241-4

@article{ff44f41821f9438bb0cd604a42227d76,

title = "Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial",

keywords = "B-CELL LYMPHOMA, RITUXIMAB PLUS CYCLOPHOSPHAMIDE, DEATH-LIGAND 1, GENE-EXPRESSION, DOXORUBICIN, SURVIVAL, VINCRISTINE, SUBTYPES, INDUCE",

author = "GS Nowakowski and W Willenbacher and Richard Greil and TS Larsen and K Patel and U Jager and RF Manges and L Trumper and H Everaus and N Kalakonda and P Brown and JM Jorgensen and D Cunningham and J DellxxxAringa and B Fox and ND Rubio and N Kilavuz and ML Casadebaig and O Manzke and J Munoz",

note = "Greil: Salzburg Cancer Research Institute and Cancer Cluster, Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2021",

doi = "10.1007/s12185-021-03241-4",

language = "English",

journal = "INTERNATIONAL JOURNAL OF HEMATOLOGY",

issn = "0925-5710",

publisher = "Carden Jennings Publishing ",

}

Nowakowski, GS, Willenbacher, W, Greil, R, Larsen, TS, Patel, K, Jager, U, Manges, RF, Trumper, L, Everaus, H, Kalakonda, N, Brown, P, Jorgensen, JM, Cunningham, D, DellxxxAringa, J, Fox, B, Rubio, ND, Kilavuz, N, Casadebaig, ML, Manzke, O & Munoz, J 2021, 'Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial', INTERNATIONAL JOURNAL OF HEMATOLOGY. https://doi.org/10.1007/s12185-021-03241-4

TY - JOUR

T1 - Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

AU - Nowakowski, GS

AU - Willenbacher, W

AU - Greil, Richard

AU - Larsen, TS

AU - Patel, K

AU - Jager, U

AU - Manges, RF

AU - Trumper, L

AU - Everaus, H

AU - Kalakonda, N

AU - Brown, P

AU - Jorgensen, JM

AU - Cunningham, D

AU - DellxxxAringa, J

AU - Fox, B

AU - Rubio, ND

AU - Kilavuz, N

AU - Casadebaig, ML

AU - Manzke, O

AU - Munoz, J

N1 - Greil: Salzburg Cancer Research Institute and Cancer Cluster, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - B-CELL LYMPHOMA

KW - RITUXIMAB PLUS CYCLOPHOSPHAMIDE

KW - DEATH-LIGAND 1

KW - GENE-EXPRESSION

KW - DOXORUBICIN

KW - SURVIVAL

KW - VINCRISTINE

KW - SUBTYPES

KW - INDUCE

U2 - 10.1007/s12185-021-03241-4

DO - 10.1007/s12185-021-03241-4

M3 - Original Article

C2 - 34797531

SN - 0925-5710

JO - INTERNATIONAL JOURNAL OF HEMATOLOGY

JF - INTERNATIONAL JOURNAL OF HEMATOLOGY

ER -